| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00072 |
1 |
| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.00068 |
1 |
| mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.00076 |
1 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00049 |
1 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.00046 |
1 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00034 |
1 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00033 |
1 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00029 |
1 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.00025 |
1 |
| mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
2.5e-06 |
1 |